nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—Doxorubicin—ovarian cancer	0.3	0.5	CbGbCtD
L-Arginine—NOS3—Doxorubicin—ovarian cancer	0.3	0.5	CbGbCtD
L-Arginine—NOS3—vein—ovarian cancer	0.0135	0.0777	CbGeAlD
L-Arginine—ASS1—oviduct—ovarian cancer	0.00832	0.0479	CbGeAlD
L-Arginine—AZIN2—myometrium—ovarian cancer	0.00729	0.042	CbGeAlD
L-Arginine—SLC7A3—decidua—ovarian cancer	0.00606	0.0349	CbGeAlD
L-Arginine—Skin necrosis—Melphalan—ovarian cancer	0.00583	0.0495	CcSEcCtD
L-Arginine—AZIN2—uterine cervix—ovarian cancer	0.00567	0.0327	CbGeAlD
L-Arginine—ASL—uterine cervix—ovarian cancer	0.00527	0.0304	CbGeAlD
L-Arginine—Extravasation—Carboplatin—ovarian cancer	0.0052	0.0442	CcSEcCtD
L-Arginine—Skin necrosis—Vinorelbine—ovarian cancer	0.00509	0.0433	CcSEcCtD
L-Arginine—SLC7A4—female reproductive system—ovarian cancer	0.00443	0.0255	CbGeAlD
L-Arginine—ASL—uterus—ovarian cancer	0.00439	0.0253	CbGeAlD
L-Arginine—ASL—female reproductive system—ovarian cancer	0.00395	0.0228	CbGeAlD
L-Arginine—AZIN2—female gonad—ovarian cancer	0.00387	0.0223	CbGeAlD
L-Arginine—SLC7A3—testis—ovarian cancer	0.00385	0.0222	CbGeAlD
L-Arginine—AZIN2—vagina—ovarian cancer	0.00384	0.0221	CbGeAlD
L-Arginine—ASL—female gonad—ovarian cancer	0.00359	0.0207	CbGeAlD
L-Arginine—SLC7A4—testis—ovarian cancer	0.00358	0.0206	CbGeAlD
L-Arginine—AZIN2—testis—ovarian cancer	0.00343	0.0198	CbGeAlD
L-Arginine—Skin necrosis—Paclitaxel—ovarian cancer	0.00342	0.0291	CcSEcCtD
L-Arginine—ASL—testis—ovarian cancer	0.00319	0.0184	CbGeAlD
L-Arginine—ARG2—epithelium—ovarian cancer	0.00298	0.0172	CbGeAlD
L-Arginine—ARG2—uterine cervix—ovarian cancer	0.00296	0.017	CbGeAlD
L-Arginine—Rash macular—Paclitaxel—ovarian cancer	0.00292	0.0248	CcSEcCtD
L-Arginine—SLC7A1—gonad—ovarian cancer	0.0029	0.0167	CbGeAlD
L-Arginine—SLC7A1—uterus—ovarian cancer	0.00288	0.0166	CbGeAlD
L-Arginine—ARG2—endometrium—ovarian cancer	0.00267	0.0154	CbGeAlD
L-Arginine—ASS1—myometrium—ovarian cancer	0.00266	0.0153	CbGeAlD
L-Arginine—SLC7A1—female reproductive system—ovarian cancer	0.00259	0.0149	CbGeAlD
L-Arginine—AZIN2—lymph node—ovarian cancer	0.00249	0.0143	CbGeAlD
L-Arginine—ARG2—gonad—ovarian cancer	0.00248	0.0143	CbGeAlD
L-Arginine—ARG2—uterus—ovarian cancer	0.00246	0.0142	CbGeAlD
L-Arginine—Extravasation—Topotecan—ovarian cancer	0.00238	0.0203	CcSEcCtD
L-Arginine—SLC7A1—female gonad—ovarian cancer	0.00236	0.0136	CbGeAlD
L-Arginine—Extravasation—Melphalan—ovarian cancer	0.00233	0.0198	CcSEcCtD
L-Arginine—ASL—lymph node—ovarian cancer	0.00231	0.0133	CbGeAlD
L-Arginine—Necrosis—Vinorelbine—ovarian cancer	0.00227	0.0193	CcSEcCtD
L-Arginine—Anorexia—Altretamine—ovarian cancer	0.00223	0.019	CcSEcCtD
L-Arginine—ARG2—female reproductive system—ovarian cancer	0.00221	0.0128	CbGeAlD
L-Arginine—Numbness—Vinorelbine—ovarian cancer	0.00215	0.0182	CcSEcCtD
L-Arginine—SLC7A1—testis—ovarian cancer	0.00209	0.012	CbGeAlD
L-Arginine—ASS1—epithelium—ovarian cancer	0.00209	0.012	CbGeAlD
L-Arginine—NOS3—epithelium—ovarian cancer	0.00208	0.012	CbGeAlD
L-Arginine—ASS1—uterine cervix—ovarian cancer	0.00207	0.0119	CbGeAlD
L-Arginine—Sensory loss—Vinorelbine—ovarian cancer	0.00205	0.0174	CcSEcCtD
L-Arginine—Extravasation—Vinorelbine—ovarian cancer	0.00204	0.0173	CcSEcCtD
L-Arginine—Decreased appetite—Altretamine—ovarian cancer	0.00204	0.0173	CcSEcCtD
L-Arginine—Injection site reaction—Melphalan—ovarian cancer	0.00202	0.0172	CcSEcCtD
L-Arginine—ARG2—female gonad—ovarian cancer	0.00202	0.0116	CbGeAlD
L-Arginine—ARG2—vagina—ovarian cancer	0.002	0.0115	CbGeAlD
L-Arginine—ASS1—decidua—ovarian cancer	0.00197	0.0114	CbGeAlD
L-Arginine—Skin necrosis—Epirubicin—ovarian cancer	0.00196	0.0166	CcSEcCtD
L-Arginine—Skin exfoliation—Melphalan—ovarian cancer	0.00194	0.0165	CcSEcCtD
L-Arginine—ASS1—endometrium—ovarian cancer	0.00187	0.0108	CbGeAlD
L-Arginine—Skin necrosis—Doxorubicin—ovarian cancer	0.00181	0.0154	CcSEcCtD
L-Arginine—ARG2—testis—ovarian cancer	0.00179	0.0103	CbGeAlD
L-Arginine—Injection site reaction—Vinorelbine—ovarian cancer	0.00177	0.015	CcSEcCtD
L-Arginine—ASS1—gonad—ovarian cancer	0.00174	0.01	CbGeAlD
L-Arginine—ASS1—uterus—ovarian cancer	0.00173	0.00995	CbGeAlD
L-Arginine—Skin exfoliation—Vinorelbine—ovarian cancer	0.0017	0.0144	CcSEcCtD
L-Arginine—SLC22A4—myometrium—ovarian cancer	0.00169	0.00976	CbGeAlD
L-Arginine—ASS1—female reproductive system—ovarian cancer	0.00155	0.00894	CbGeAlD
L-Arginine—NOS3—female reproductive system—ovarian cancer	0.00155	0.00891	CbGeAlD
L-Arginine—Lethargy—Topotecan—ovarian cancer	0.00154	0.0131	CcSEcCtD
L-Arginine—Necrosis—Paclitaxel—ovarian cancer	0.00152	0.013	CcSEcCtD
L-Arginine—SLC7A1—lymph node—ovarian cancer	0.00151	0.00873	CbGeAlD
L-Arginine—SLC16A10—epithelium—ovarian cancer	0.00149	0.0086	CbGeAlD
L-Arginine—Vomiting—Altretamine—ovarian cancer	0.00149	0.0127	CcSEcCtD
L-Arginine—ASS1—female gonad—ovarian cancer	0.00141	0.00814	CbGeAlD
L-Arginine—ASS1—vagina—ovarian cancer	0.0014	0.00809	CbGeAlD
L-Arginine—NOS3—vagina—ovarian cancer	0.0014	0.00806	CbGeAlD
L-Arginine—Nausea—Altretamine—ovarian cancer	0.00139	0.0118	CcSEcCtD
L-Arginine—Sensory loss—Paclitaxel—ovarian cancer	0.00138	0.0117	CcSEcCtD
L-Arginine—Extravasation—Paclitaxel—ovarian cancer	0.00137	0.0117	CcSEcCtD
L-Arginine—Lethargy—Vinorelbine—ovarian cancer	0.00132	0.0112	CcSEcCtD
L-Arginine—ARG2—lymph node—ovarian cancer	0.0013	0.00746	CbGeAlD
L-Arginine—Necrosis—Docetaxel—ovarian cancer	0.00129	0.011	CcSEcCtD
L-Arginine—SLC22A4—decidua—ovarian cancer	0.00126	0.00724	CbGeAlD
L-Arginine—ASS1—testis—ovarian cancer	0.00125	0.00722	CbGeAlD
L-Arginine—NOS3—testis—ovarian cancer	0.00125	0.00719	CbGeAlD
L-Arginine—SLC16A10—gonad—ovarian cancer	0.00124	0.00715	CbGeAlD
L-Arginine—SLC22A4—endometrium—ovarian cancer	0.00119	0.00687	CbGeAlD
L-Arginine—Injection site reaction—Paclitaxel—ovarian cancer	0.00119	0.0101	CcSEcCtD
L-Arginine—Extravasation—Docetaxel—ovarian cancer	0.00116	0.00988	CcSEcCtD
L-Arginine—Skin exfoliation—Paclitaxel—ovarian cancer	0.00114	0.00971	CcSEcCtD
L-Arginine—SLC22A5—myometrium—ovarian cancer	0.00112	0.00646	CbGeAlD
L-Arginine—Sweating—Topotecan—ovarian cancer	0.00112	0.00948	CcSEcCtD
L-Arginine—SLC16A10—female reproductive system—ovarian cancer	0.00111	0.00639	CbGeAlD
L-Arginine—Hypoaesthesia—Topotecan—ovarian cancer	0.00104	0.00883	CcSEcCtD
L-Arginine—Injection site reaction—Docetaxel—ovarian cancer	0.00101	0.00857	CcSEcCtD
L-Arginine—SLC16A10—vagina—ovarian cancer	0.001	0.00578	CbGeAlD
L-Arginine—SLC22A4—female reproductive system—ovarian cancer	0.000988	0.00569	CbGeAlD
L-Arginine—Swelling—Paclitaxel—ovarian cancer	0.000984	0.00837	CcSEcCtD
L-Arginine—Skin exfoliation—Docetaxel—ovarian cancer	0.000968	0.00823	CcSEcCtD
L-Arginine—Flushing—Melphalan—ovarian cancer	0.000949	0.00806	CcSEcCtD
L-Arginine—SLC22A4—bone marrow—ovarian cancer	0.000932	0.00537	CbGeAlD
L-Arginine—ASS1—lymph node—ovarian cancer	0.000908	0.00523	CbGeAlD
L-Arginine—NOS3—lymph node—ovarian cancer	0.000905	0.00521	CbGeAlD
L-Arginine—SLC16A10—testis—ovarian cancer	0.000895	0.00516	CbGeAlD
L-Arginine—SLC22A4—vagina—ovarian cancer	0.000893	0.00515	CbGeAlD
L-Arginine—Hypoaesthesia—Vinorelbine—ovarian cancer	0.000889	0.00755	CcSEcCtD
L-Arginine—Lethargy—Paclitaxel—ovarian cancer	0.000886	0.00753	CcSEcCtD
L-Arginine—SLC22A5—uterine cervix—ovarian cancer	0.000872	0.00503	CbGeAlD
L-Arginine—Necrosis—Epirubicin—ovarian cancer	0.000871	0.00741	CcSEcCtD
L-Arginine—Swelling—Docetaxel—ovarian cancer	0.000834	0.00709	CcSEcCtD
L-Arginine—Flushing—Vinorelbine—ovarian cancer	0.000829	0.00704	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—ovarian cancer	0.000806	0.00685	CcSEcCtD
L-Arginine—Anorexia—Chlorambucil—ovarian cancer	0.000794	0.00675	CcSEcCtD
L-Arginine—SLC22A5—endometrium—ovarian cancer	0.000789	0.00455	CbGeAlD
L-Arginine—Extravasation—Epirubicin—ovarian cancer	0.000784	0.00666	CcSEcCtD
L-Arginine—Lethargy—Docetaxel—ovarian cancer	0.000751	0.00638	CcSEcCtD
L-Arginine—Anaphylactic shock—Topotecan—ovarian cancer	0.000742	0.0063	CcSEcCtD
L-Arginine—Anaphylactic shock—Melphalan—ovarian cancer	0.000726	0.00617	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—ovarian cancer	0.000725	0.00616	CcSEcCtD
L-Arginine—Decreased appetite—Chlorambucil—ovarian cancer	0.000724	0.00616	CcSEcCtD
L-Arginine—Hyperhidrosis—Topotecan—ovarian cancer	0.000717	0.00609	CcSEcCtD
L-Arginine—Tachycardia—Melphalan—ovarian cancer	0.000709	0.00602	CcSEcCtD
L-Arginine—Anorexia—Topotecan—ovarian cancer	0.000707	0.00601	CcSEcCtD
L-Arginine—Anorexia—Melphalan—ovarian cancer	0.000692	0.00588	CcSEcCtD
L-Arginine—Injection site reaction—Epirubicin—ovarian cancer	0.00068	0.00578	CcSEcCtD
L-Arginine—SLC22A5—female reproductive system—ovarian cancer	0.000654	0.00377	CbGeAlD
L-Arginine—Skin exfoliation—Epirubicin—ovarian cancer	0.000653	0.00555	CcSEcCtD
L-Arginine—SLC16A10—lymph node—ovarian cancer	0.000649	0.00374	CbGeAlD
L-Arginine—Decreased appetite—Topotecan—ovarian cancer	0.000645	0.00548	CcSEcCtD
L-Arginine—Haematuria—Paclitaxel—ovarian cancer	0.000638	0.00542	CcSEcCtD
L-Arginine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000635	0.00539	CcSEcCtD
L-Arginine—Decreased appetite—Melphalan—ovarian cancer	0.000631	0.00537	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—ovarian cancer	0.000629	0.00535	CcSEcCtD
L-Arginine—Tachycardia—Vinorelbine—ovarian cancer	0.000619	0.00526	CcSEcCtD
L-Arginine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000614	0.00522	CcSEcCtD
L-Arginine—Anorexia—Vinorelbine—ovarian cancer	0.000605	0.00514	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—ovarian cancer	0.000604	0.00513	CcSEcCtD
L-Arginine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000598	0.00508	CcSEcCtD
L-Arginine—SLC22A5—female gonad—ovarian cancer	0.000595	0.00343	CbGeAlD
L-Arginine—SLC22A5—vagina—ovarian cancer	0.000591	0.00341	CbGeAlD
L-Arginine—SLC22A4—lymph node—ovarian cancer	0.000578	0.00333	CbGeAlD
L-Arginine—Flushing—Paclitaxel—ovarian cancer	0.000558	0.00474	CcSEcCtD
L-Arginine—Decreased appetite—Vinorelbine—ovarian cancer	0.000552	0.00469	CcSEcCtD
L-Arginine—Hypersensitivity—Topotecan—ovarian cancer	0.000547	0.00464	CcSEcCtD
L-Arginine—Hypersensitivity—Melphalan—ovarian cancer	0.000535	0.00455	CcSEcCtD
L-Arginine—Vomiting—Chlorambucil—ovarian cancer	0.00053	0.0045	CcSEcCtD
L-Arginine—SLC22A5—testis—ovarian cancer	0.000527	0.00304	CbGeAlD
L-Arginine—Hypoaesthesia—Docetaxel—ovarian cancer	0.000507	0.00431	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—ovarian cancer	0.000507	0.00431	CcSEcCtD
L-Arginine—Nausea—Chlorambucil—ovarian cancer	0.000495	0.00421	CcSEcCtD
L-Arginine—Flushing—Docetaxel—ovarian cancer	0.000473	0.00402	CcSEcCtD
L-Arginine—Vomiting—Topotecan—ovarian cancer	0.000472	0.00401	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—ovarian cancer	0.000469	0.00398	CcSEcCtD
L-Arginine—Rash—Topotecan—ovarian cancer	0.000468	0.00397	CcSEcCtD
L-Arginine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000468	0.00397	CcSEcCtD
L-Arginine—Dermatitis—Topotecan—ovarian cancer	0.000467	0.00397	CcSEcCtD
L-Arginine—Headache—Topotecan—ovarian cancer	0.000465	0.00395	CcSEcCtD
L-Arginine—Vomiting—Melphalan—ovarian cancer	0.000462	0.00392	CcSEcCtD
L-Arginine—Rash—Melphalan—ovarian cancer	0.000458	0.00389	CcSEcCtD
L-Arginine—Dermatitis—Melphalan—ovarian cancer	0.000458	0.00389	CcSEcCtD
L-Arginine—Nausea—Topotecan—ovarian cancer	0.000441	0.00374	CcSEcCtD
L-Arginine—Nausea—Melphalan—ovarian cancer	0.000431	0.00367	CcSEcCtD
L-Arginine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000427	0.00363	CcSEcCtD
L-Arginine—Tachycardia—Paclitaxel—ovarian cancer	0.000417	0.00354	CcSEcCtD
L-Arginine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000413	0.00351	CcSEcCtD
L-Arginine—Anorexia—Paclitaxel—ovarian cancer	0.000407	0.00346	CcSEcCtD
L-Arginine—Vomiting—Vinorelbine—ovarian cancer	0.000403	0.00343	CcSEcCtD
L-Arginine—Rash—Vinorelbine—ovarian cancer	0.0004	0.0034	CcSEcCtD
L-Arginine—Dermatitis—Vinorelbine—ovarian cancer	0.0004	0.0034	CcSEcCtD
L-Arginine—Headache—Vinorelbine—ovarian cancer	0.000398	0.00338	CcSEcCtD
L-Arginine—SLC22A5—lymph node—ovarian cancer	0.000382	0.0022	CbGeAlD
L-Arginine—Nausea—Vinorelbine—ovarian cancer	0.000377	0.0032	CcSEcCtD
L-Arginine—Decreased appetite—Paclitaxel—ovarian cancer	0.000371	0.00315	CcSEcCtD
L-Arginine—Sweating—Epirubicin—ovarian cancer	0.000367	0.00312	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—ovarian cancer	0.000365	0.0031	CcSEcCtD
L-Arginine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000362	0.00307	CcSEcCtD
L-Arginine—Tachycardia—Docetaxel—ovarian cancer	0.000353	0.003	CcSEcCtD
L-Arginine—Anorexia—Docetaxel—ovarian cancer	0.000345	0.00293	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000342	0.0029	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—ovarian cancer	0.000339	0.00288	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—ovarian cancer	0.000338	0.00287	CcSEcCtD
L-Arginine—Flushing—Epirubicin—ovarian cancer	0.000319	0.00271	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000316	0.00269	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—ovarian cancer	0.000314	0.00267	CcSEcCtD
L-Arginine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000314	0.00267	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—ovarian cancer	0.000295	0.00251	CcSEcCtD
L-Arginine—Vomiting—Paclitaxel—ovarian cancer	0.000271	0.00231	CcSEcCtD
L-Arginine—Rash—Paclitaxel—ovarian cancer	0.000269	0.00229	CcSEcCtD
L-Arginine—Dermatitis—Paclitaxel—ovarian cancer	0.000269	0.00228	CcSEcCtD
L-Arginine—Headache—Paclitaxel—ovarian cancer	0.000267	0.00227	CcSEcCtD
L-Arginine—Hypersensitivity—Docetaxel—ovarian cancer	0.000267	0.00227	CcSEcCtD
L-Arginine—Nausea—Paclitaxel—ovarian cancer	0.000254	0.00215	CcSEcCtD
L-Arginine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000244	0.00207	CcSEcCtD
L-Arginine—Tachycardia—Epirubicin—ovarian cancer	0.000238	0.00202	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000236	0.002	CcSEcCtD
L-Arginine—Anorexia—Epirubicin—ovarian cancer	0.000233	0.00198	CcSEcCtD
L-Arginine—Vomiting—Docetaxel—ovarian cancer	0.00023	0.00195	CcSEcCtD
L-Arginine—Rash—Docetaxel—ovarian cancer	0.000228	0.00194	CcSEcCtD
L-Arginine—Dermatitis—Docetaxel—ovarian cancer	0.000228	0.00194	CcSEcCtD
L-Arginine—Headache—Docetaxel—ovarian cancer	0.000227	0.00193	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000226	0.00192	CcSEcCtD
L-Arginine—Tachycardia—Doxorubicin—ovarian cancer	0.00022	0.00187	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000218	0.00185	CcSEcCtD
L-Arginine—Anorexia—Doxorubicin—ovarian cancer	0.000215	0.00183	CcSEcCtD
L-Arginine—Nausea—Docetaxel—ovarian cancer	0.000215	0.00183	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—ovarian cancer	0.000212	0.0018	CcSEcCtD
L-Arginine—Decreased appetite—Doxorubicin—ovarian cancer	0.000196	0.00167	CcSEcCtD
L-Arginine—Hypersensitivity—Epirubicin—ovarian cancer	0.00018	0.00153	CcSEcCtD
L-Arginine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000166	0.00141	CcSEcCtD
L-Arginine—Vomiting—Epirubicin—ovarian cancer	0.000155	0.00132	CcSEcCtD
L-Arginine—Rash—Epirubicin—ovarian cancer	0.000154	0.00131	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—ovarian cancer	0.000154	0.00131	CcSEcCtD
L-Arginine—Headache—Epirubicin—ovarian cancer	0.000153	0.0013	CcSEcCtD
L-Arginine—Nausea—Epirubicin—ovarian cancer	0.000145	0.00123	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—ovarian cancer	0.000144	0.00122	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MAPK1—ovarian cancer	0.000142	0.0013	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—ovarian cancer	0.000142	0.0013	CbGpPWpGaD
L-Arginine—Rash—Doxorubicin—ovarian cancer	0.000142	0.00121	CcSEcCtD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—ovarian cancer	0.000142	0.0013	CbGpPWpGaD
L-Arginine—Dermatitis—Doxorubicin—ovarian cancer	0.000142	0.00121	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—MAPK3—ovarian cancer	0.000142	0.00129	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TYMS—ovarian cancer	0.000142	0.00129	CbGpPWpGaD
L-Arginine—Headache—Doxorubicin—ovarian cancer	0.000141	0.0012	CcSEcCtD
L-Arginine—NOS3—Disease—BCL9—ovarian cancer	0.000141	0.00129	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—YAP1—ovarian cancer	0.000135	0.00124	CbGpPWpGaD
L-Arginine—NOS2—Disease—PPP1CC—ovarian cancer	0.000135	0.00123	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—MAPK1—ovarian cancer	0.000135	0.00123	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—ovarian cancer	0.000134	0.00114	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—ovarian cancer	0.000133	0.00121	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SPARC—ovarian cancer	0.000132	0.00121	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—ovarian cancer	0.000131	0.0012	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PPP2R1A—ovarian cancer	0.000129	0.00117	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000128	0.00116	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—ovarian cancer	0.000128	0.00116	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—MAPK3—ovarian cancer	0.000126	0.00115	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—ovarian cancer	0.000125	0.00114	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CAV1—ovarian cancer	0.000125	0.00114	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—ovarian cancer	0.000125	0.00114	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SOD1—ovarian cancer	0.000124	0.00113	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—ovarian cancer	0.000124	0.00113	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ERBB2—ovarian cancer	0.000124	0.00113	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PPP2R1A—ovarian cancer	0.000123	0.00112	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—MTOR—ovarian cancer	0.000122	0.00111	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ovarian cancer	0.000122	0.00111	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DLC1—ovarian cancer	0.000121	0.00111	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—MAPK1—ovarian cancer	0.00012	0.00109	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—ovarian cancer	0.00012	0.00109	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ABCB1—ovarian cancer	0.000119	0.00109	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—MAPK3—ovarian cancer	0.000119	0.00108	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TYMS—ovarian cancer	0.000117	0.00107	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PTEN—ovarian cancer	0.000114	0.00104	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CAV1—ovarian cancer	0.000114	0.00104	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CG—ovarian cancer	0.000114	0.00104	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000113	0.00103	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—ovarian cancer	0.000113	0.00103	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—MAPK1—ovarian cancer	0.000113	0.00103	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—ovarian cancer	0.000113	0.00103	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000111	0.00102	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—FASN—ovarian cancer	0.00011	0.00101	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL6—ovarian cancer	0.000109	0.000998	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000109	0.000997	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SLC5A5—ovarian cancer	0.000109	0.00099	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000108	0.000981	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—ovarian cancer	0.000107	0.000972	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTEN—ovarian cancer	0.000106	0.000962	CbGpPWpGaD
L-Arginine—NOS3—Disease—PPP1CC—ovarian cancer	0.000105	0.000957	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SLC2A1—ovarian cancer	0.000105	0.000957	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CG—ovarian cancer	0.000104	0.000948	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PIK3CA—ovarian cancer	0.000104	0.000946	CbGpPWpGaD
L-Arginine—NOS2—Disease—HDAC6—ovarian cancer	0.000102	0.000934	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYTB—ovarian cancer	0.000101	0.000917	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP1B1—ovarian cancer	0.000101	0.000917	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CD—ovarian cancer	9.99e-05	0.000911	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BCL9—ovarian cancer	9.89e-05	0.000902	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PIK3CA—ovarian cancer	9.79e-05	0.000893	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SOD1—ovarian cancer	9.62e-05	0.000878	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—ovarian cancer	9.6e-05	0.000875	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PPP2R1A—ovarian cancer	9.57e-05	0.000873	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—ovarian cancer	9.56e-05	0.000872	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CAV1—ovarian cancer	9.45e-05	0.000862	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—STAT3—ovarian cancer	9.44e-05	0.000861	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—IL6—ovarian cancer	9.19e-05	0.000838	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CD—ovarian cancer	9.14e-05	0.000833	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—CAV1—ovarian cancer	9.06e-05	0.000826	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—ovarian cancer	9.06e-05	0.000826	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPP2R1A—ovarian cancer	8.92e-05	0.000813	CbGpPWpGaD
L-Arginine—NOS2—Disease—XIAP—ovarian cancer	8.88e-05	0.00081	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPP1CC—ovarian cancer	8.79e-05	0.000802	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—BRIP1—ovarian cancer	8.79e-05	0.000802	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CB—ovarian cancer	8.71e-05	0.000794	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—IL6—ovarian cancer	8.67e-05	0.000791	CbGpPWpGaD
L-Arginine—NOS2—Disease—SMARCA4—ovarian cancer	8.66e-05	0.000789	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.63e-05	0.000787	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CG—ovarian cancer	8.61e-05	0.000785	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—MAPK1—ovarian cancer	8.58e-05	0.000782	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—ovarian cancer	8.58e-05	0.000782	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	8.51e-05	0.000776	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.49e-05	0.000775	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—ovarian cancer	8.48e-05	0.000773	CbGpPWpGaD
L-Arginine—NOS2—Disease—EREG—ovarian cancer	8.45e-05	0.00077	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ABCB1—ovarian cancer	8.28e-05	0.000755	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CG—ovarian cancer	8.25e-05	0.000753	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.22e-05	0.00075	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TYMS—ovarian cancer	8.13e-05	0.000742	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—ovarian cancer	8.1e-05	0.000739	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—ovarian cancer	8e-05	0.00073	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CB—ovarian cancer	7.96e-05	0.000726	CbGpPWpGaD
L-Arginine—NOS3—Disease—HDAC6—ovarian cancer	7.95e-05	0.000725	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DOK1—ovarian cancer	7.82e-05	0.000713	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—ovarian cancer	7.81e-05	0.000712	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CD—ovarian cancer	7.57e-05	0.00069	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTEN—ovarian cancer	7.52e-05	0.000686	CbGpPWpGaD
L-Arginine—NOS2—Disease—FASN—ovarian cancer	7.39e-05	0.000674	CbGpPWpGaD
L-Arginine—NOS2—Disease—PARP1—ovarian cancer	7.36e-05	0.000671	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPP1CC—ovarian cancer	7.35e-05	0.00067	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CD—ovarian cancer	7.26e-05	0.000662	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—IL6—ovarian cancer	7.15e-05	0.000652	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CAV1—ovarian cancer	7.04e-05	0.000642	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC2A1—ovarian cancer	7.02e-05	0.00064	CbGpPWpGaD
L-Arginine—NOS3—Disease—XIAP—ovarian cancer	6.9e-05	0.000629	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—ovarian cancer	6.89e-05	0.000628	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—ovarian cancer	6.88e-05	0.000628	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—ovarian cancer	6.83e-05	0.000623	CbGpPWpGaD
L-Arginine—NOS3—Disease—SMARCA4—ovarian cancer	6.72e-05	0.000613	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CB—ovarian cancer	6.6e-05	0.000602	CbGpPWpGaD
L-Arginine—NOS3—Disease—EREG—ovarian cancer	6.56e-05	0.000598	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CAV1—ovarian cancer	6.55e-05	0.000598	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.49e-05	0.000592	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CG—ovarian cancer	6.41e-05	0.000584	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CB—ovarian cancer	6.32e-05	0.000577	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—ovarian cancer	6.08e-05	0.000555	CbGpPWpGaD
L-Arginine—NOS2—Disease—PPP2R1A—ovarian cancer	5.97e-05	0.000544	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CG—ovarian cancer	5.97e-05	0.000544	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—YAP1—ovarian cancer	5.9e-05	0.000538	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—ovarian cancer	5.81e-05	0.00053	CbGpPWpGaD
L-Arginine—NOS3—Disease—FASN—ovarian cancer	5.74e-05	0.000523	CbGpPWpGaD
L-Arginine—NOS3—Disease—PARP1—ovarian cancer	5.71e-05	0.000521	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—ovarian cancer	5.7e-05	0.00052	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CD—ovarian cancer	5.63e-05	0.000514	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC6—ovarian cancer	5.57e-05	0.000508	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A1—ovarian cancer	5.45e-05	0.000497	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—ovarian cancer	5.31e-05	0.000484	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CD—ovarian cancer	5.25e-05	0.000479	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—ovarian cancer	4.94e-05	0.00045	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—YAP1—ovarian cancer	4.93e-05	0.00045	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CB—ovarian cancer	4.91e-05	0.000448	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—ovarian cancer	4.88e-05	0.000445	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—ovarian cancer	4.85e-05	0.000443	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—XIAP—ovarian cancer	4.83e-05	0.00044	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—FASN—ovarian cancer	4.81e-05	0.000438	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—ovarian cancer	4.74e-05	0.000433	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC5A5—ovarian cancer	4.73e-05	0.000431	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMARCA4—ovarian cancer	4.71e-05	0.000429	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK3—ovarian cancer	4.67e-05	0.000426	CbGpPWpGaD
L-Arginine—NOS3—Disease—PPP2R1A—ovarian cancer	4.64e-05	0.000423	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EREG—ovarian cancer	4.59e-05	0.000419	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CB—ovarian cancer	4.57e-05	0.000417	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A1—ovarian cancer	4.57e-05	0.000416	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—ovarian cancer	4.51e-05	0.000411	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK1—ovarian cancer	4.44e-05	0.000405	CbGpPWpGaD
L-Arginine—NOS2—Disease—CAV1—ovarian cancer	4.39e-05	0.0004	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1B1—ovarian cancer	4.38e-05	0.000399	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—ovarian cancer	4.34e-05	0.000395	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PGR—ovarian cancer	4.3e-05	0.000393	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—ovarian cancer	4.2e-05	0.000383	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6ST—ovarian cancer	4.16e-05	0.000379	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—ovarian cancer	4.02e-05	0.000367	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PARP1—ovarian cancer	4e-05	0.000365	CbGpPWpGaD
L-Arginine—NOS2—Disease—APC—ovarian cancer	4e-05	0.000364	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—ovarian cancer	3.97e-05	0.000362	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—ovarian cancer	3.95e-05	0.00036	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPP2R1A—ovarian cancer	3.88e-05	0.000354	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—ovarian cancer	3.86e-05	0.000352	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—ovarian cancer	3.83e-05	0.00035	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—ovarian cancer	3.79e-05	0.000345	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—ovarian cancer	3.73e-05	0.00034	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—ovarian cancer	3.68e-05	0.000336	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK3—ovarian cancer	3.63e-05	0.000331	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—ovarian cancer	3.6e-05	0.000329	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—ovarian cancer	3.57e-05	0.000325	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—ovarian cancer	3.54e-05	0.000323	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CD—ovarian cancer	3.51e-05	0.00032	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK1—ovarian cancer	3.45e-05	0.000315	CbGpPWpGaD
L-Arginine—NOS3—Disease—CAV1—ovarian cancer	3.41e-05	0.000311	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—ovarian cancer	3.29e-05	0.0003	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—ovarian cancer	3.26e-05	0.000297	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPP2R1A—ovarian cancer	3.25e-05	0.000296	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6ST—ovarian cancer	3.23e-05	0.000294	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—ovarian cancer	3.15e-05	0.000287	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—ovarian cancer	3.1e-05	0.000283	CbGpPWpGaD
L-Arginine—NOS3—Disease—APC—ovarian cancer	3.1e-05	0.000283	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CB—ovarian cancer	3.06e-05	0.000279	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTOR—ovarian cancer	3.06e-05	0.000279	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—ovarian cancer	2.99e-05	0.000273	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—ovarian cancer	2.9e-05	0.000264	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—ovarian cancer	2.87e-05	0.000262	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CAV1—ovarian cancer	2.85e-05	0.00026	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—ovarian cancer	2.79e-05	0.000254	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—ovarian cancer	2.77e-05	0.000253	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CD—ovarian cancer	2.73e-05	0.000249	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—ovarian cancer	2.71e-05	0.000248	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—ovarian cancer	2.65e-05	0.000241	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—ovarian cancer	2.6e-05	0.000237	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—ovarian cancer	2.58e-05	0.000235	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—ovarian cancer	2.45e-05	0.000223	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—ovarian cancer	2.41e-05	0.00022	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CAV1—ovarian cancer	2.39e-05	0.000218	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CB—ovarian cancer	2.38e-05	0.000217	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTOR—ovarian cancer	2.38e-05	0.000217	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—ovarian cancer	2.37e-05	0.000216	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—ovarian cancer	2.36e-05	0.000215	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ESR1—ovarian cancer	2.3e-05	0.00021	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CD—ovarian cancer	2.28e-05	0.000208	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—ovarian cancer	2.28e-05	0.000208	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6ST—ovarian cancer	2.26e-05	0.000206	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK3—ovarian cancer	2.26e-05	0.000206	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—ovarian cancer	2.23e-05	0.000203	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—ovarian cancer	2.2e-05	0.000201	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APC—ovarian cancer	2.17e-05	0.000198	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—ovarian cancer	2.17e-05	0.000198	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK1—ovarian cancer	2.15e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—ovarian cancer	2.15e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—ovarian cancer	2.11e-05	0.000192	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—ovarian cancer	2.05e-05	0.000187	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—ovarian cancer	2.03e-05	0.000185	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CB—ovarian cancer	1.99e-05	0.000182	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CD—ovarian cancer	1.91e-05	0.000174	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—ovarian cancer	1.87e-05	0.00017	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—ovarian cancer	1.84e-05	0.000168	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—ovarian cancer	1.83e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK3—ovarian cancer	1.76e-05	0.00016	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—ovarian cancer	1.73e-05	0.000157	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—ovarian cancer	1.72e-05	0.000157	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—ovarian cancer	1.71e-05	0.000156	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—ovarian cancer	1.69e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK1—ovarian cancer	1.67e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—ovarian cancer	1.67e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CB—ovarian cancer	1.66e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MTOR—ovarian cancer	1.66e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—ovarian cancer	1.65e-05	0.000151	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—ovarian cancer	1.6e-05	0.000146	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—ovarian cancer	1.58e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—ovarian cancer	1.56e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—ovarian cancer	1.53e-05	0.00014	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—ovarian cancer	1.53e-05	0.000139	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—ovarian cancer	1.52e-05	0.000139	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—ovarian cancer	1.49e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—ovarian cancer	1.48e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—ovarian cancer	1.45e-05	0.000132	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—ovarian cancer	1.45e-05	0.000132	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—ovarian cancer	1.44e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—ovarian cancer	1.34e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—ovarian cancer	1.3e-05	0.000118	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—ovarian cancer	1.29e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—ovarian cancer	1.28e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—ovarian cancer	1.28e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK3—ovarian cancer	1.23e-05	0.000112	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—ovarian cancer	1.21e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—ovarian cancer	1.2e-05	0.000109	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—ovarian cancer	1.18e-05	0.000108	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK1—ovarian cancer	1.17e-05	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—ovarian cancer	1.17e-05	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—ovarian cancer	1.1e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—ovarian cancer	1.01e-05	9.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—ovarian cancer	9.91e-06	9.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—ovarian cancer	9.82e-06	8.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—ovarian cancer	9.39e-06	8.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—ovarian cancer	8.99e-06	8.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—ovarian cancer	8.29e-06	7.56e-05	CbGpPWpGaD
